A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects

NCT01803412 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophies

Interventions

DRUG: Drisapersen
DRUG: Drisapersen
DRUG: Drisapersen

Sponsor

BioMarin Pharmaceutical